DelSite, Inc. (DelSite) is a global provider of medical, nutraceutical, consumer and raw material products. It is the market leader in the research, development and marketing of products containing polymeric polysaccharides derived from natural sources. The company operates in the United States, Costa Rica, South America and Europe. The company is headquartered in Texas, the US.
On October 1, 2009, Nanotherapeutics, Inc., a medical device company, has acquired DelSite. The assets acquired include the patented, naturally derived, biocompatible, resorbable biopolymer GelSite, the GelVac nasal powder platform technology, lab equipment, intellectual property, and other related products, manufacturing facilities located in Irving and Costa Rica and a research lab located in Texas.